The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.
Age greater than or equal to 18 years
Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.
Minors under 18 years of age.
Women with mental disabilities.
Major congenital fetal anomaly.